Xenetic Biosciences, Inc. revenue breakdown overview

Xenetic Biosciences, Inc. revenue for the last year amounted to 2.50 M USD, the most of which — 2.54 M USD — came from its highest performing source at the moment, Cell-based Therapeutics, the year earlier bringing 1.71 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Xenetic Biosciences, Inc. 2.54 M USD, and the year before that — 1.71 M USD.